Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
tucatinib erbb2 tyrosine kinase receptor NA Successful target TTD , DGIDB Breast[MeSHID:D001940]
Brain[MeSHID:D001921]
Diagnosis[MeSHID:D003933]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Adenocarcinoma[MeSHID:D000230]
Stomach[MeSHID:D013270]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.14 approved inhibitor
tucatinib receptor tyrosine-protein kinase erbb-2 small molecule NA drugbank , DGIDB Breast[MeSHID:D001940]
Brain[MeSHID:D001921]
Diagnosis[MeSHID:D003933]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Adenocarcinoma[MeSHID:D000230]
Stomach[MeSHID:D013270]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.14 approved,investigational inhibitor
tucatinib erbb2 tyrosine kinase receptor NA Successful target TTD , DGIDB Breast[MeSHID:D001940]
Brain[MeSHID:D001921]
Diagnosis[MeSHID:D003933]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Adenocarcinoma[MeSHID:D000230]
Stomach[MeSHID:D013270]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.14 approved unknown
tucatinib receptor tyrosine-protein kinase erbb-3 small molecule NA drugbank Breast[MeSHID:D001940]
Brain[MeSHID:D001921]
Diagnosis[MeSHID:D003933]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Adenocarcinoma[MeSHID:D000230]
Stomach[MeSHID:D013270]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
click here to return to the previous page